Reach Capital floats €1bn-a-year GP-led budgets for CDPQ and Allianz

Reach Capital's William Barrett has put a number on what the GP-led secondaries market could look like with standing buyers in it: €1 billion a year from CDPQ and €1 billion a year from Allianz, a combined €2 billion of recurring demand placed in front of sponsors. The published extract presents those figures as a hypothetical rather than an announced budget, and the difference matters more than the arithmetic, because the proposal concerns how the buy side of GP-led transactions gets organised.

PWD's records show the week's closings made the same point from the other direction: Sun Capital wrapped its second continuation vehicle of 2026 for Anderson Global, giving Fund VIII limited partners a liquidity option or the chance to roll, with no price, no size and no lead buyer attached to either path. A $4.7 billion Orix–Anchorage Capital GP stake printed with no asset mark, and the only asset-level price to surface all week came from a bank's $101 million balance-sheet sale.

A standing annual budget from an institutional allocator would change a GP-led process in one specific way: a sponsor would know, before convening an LP advisory committee, roughly how much of a vehicle could be pre-placed, and the buyer would be underwriting a pipeline rather than a single company's cash flows. Neither institution has announced an allocation, the figure arrives as a hypothetical in a published extract, and a recurring €1 billion commitment from each would be a different instrument from the one-off approvals that populate the market today — one that would have to be sized, papered and governed before it bought anything.

The case for arranging demand in advance rests on what has not been happening on the LP-led side. BDO's research pairs a longer tail of funds running past five years — the supply that should be feeding the secondaries market — with sponsors who tell surveyors they expect to buy at higher prices. The pattern points to books that price slowly rather than cheaply, and to sellers who would rather hold than clear below a mark they still believe in.

If the LP-led route keeps stalling, the argument for pre-arranged GP-led capacity gets easier to make to an allocator, because it turns an episodic auction into something closer to a programme. From the sponsor's side, the same research explains why that demand is worth pre-arranging: a fund running past its original term leaves the sponsor holding assets it cannot easily sell and LPs who want an exit, and a continuation vehicle answers both problems by handing the LPs a choice and the sponsor a longer runway. The more funds sit in that tail, the more regularly those vehicles have to be launched, and the more a buyer who has committed to a yearly volume is worth having.

Whether either institution wants that programme is a separate question from whether the arithmetic works. A recurring budget commits capital against deal flow an allocator cannot examine in advance, and what it buys in return is standing access to vehicles that today are syndicated one at a time. Barrett's numbers amount to an argument that the constraint on GP-led volume sits with the buy side's willingness to commit early rather than with the supply of assets, and that argument would be considerably stronger if one of this week's three unpriced vehicles had disclosed a number.

There is adjacent logic in structures that hand a buyer a defined position ahead of a bespoke underwriting — preferred equity sized against a portfolio, a strip of assets sold outright, a management company stake priced off its fee stream — each converting an uncertain future into a contract with terms. A €1 billion annual budget for GP-led deals applies the same move to deal flow rather than to assets, as a version not tied to any particular portfolio. Whether the institutions named would accept terms that general is left open.

For all that forward demand, the one secondaries close this week with a figure attached was small enough to disappear inside a single budget line. Ibex wrapped its second Israel-focused secondaries fund at $87 million, more than doubling its predecessor, as AltAssets reported on 28 September. The accessible account carries no LP base, no target and no strategy detail beyond the regional focus, which leaves the doubling as the only element of the raise that can be weighed from outside. In a week whose headline number was €1 billion a year, an $87 million close is either a reminder of how small most dedicated secondaries vehicles remain or a measure of how much of the strategy is still being built, and the gap between those two readings is the gap between the market Barrett is pitching and the market Ibex is fundraising into.

Credit produced the week's other sized launch, Fidelity's $451 million real estate debt fund, while the secondaries closings in the same window attached nothing at all, not even a vehicle size — two private-market vehicles raised inside the same calendar, one with a number.

The choice inside a continuation vehicle is narrower than it looks: a limited partner who takes the liquidity option sells at a price the process sets, while one who rolls stays exposed to the same asset through a new vehicle, and neither outcome reaches the public record with a figure attached. The closing becomes the only published fact, which leaves an LP weighing the option against the roll with almost nothing from outside the deal to weigh it on.

The other large secondaries transaction of the week carried a price of a different kind. The $4.7 billion Orix–Anchorage Capital GP stake values a manager's fee stream, not a portfolio, and nothing in it establishes what the companies inside any continuation vehicle are worth. Secondaries capital is finding ways to move — through management company economics, through a bank's balance sheet, through continuation vehicles that close without a mark — while the asset-level price stays the scarcest input in the market. The arrangement works well enough for everyone inside it: a sponsor brings a continuation vehicle to an LP advisory committee without a third-party mark, a lead buyer underwrites the sponsor's valuation, and the LPs choose between a liquidity option and a roll on terms they can see and the public cannot.

For the Fund VIII limited partners in Sun Capital's Anderson Global vehicle, the choice on the table is a liquidity option or a roll, and neither comes with a published price. Whether CDPQ and Allianz have an interest in a standing commitment remains open; the coverage does not say whether either institution has responded, and no budget has been announced. The nearer test is smaller than a €1 billion line: one of this week's three unpriced vehicles eventually disclosing a number.